Awareness of Lung Cancer Screening Availability Remains Low
Only one-third (33%) of surveyed Americans were aware that low-dose CT scans are available individuals at high-risk of lung cancer.
Only one-third (33%) of surveyed Americans were aware that low-dose CT scans are available individuals at high-risk of lung cancer.
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
The FDA authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application pathway.
Currently smoking is associated with a lower risk of developing Parkinson’s disease, but quitting smoking was associated with a lower risk of death.
A chemical cocktail of metal nanoparticles and reactive peroxides in aged e-cigarette aerosols creates a unique profile of respiratory health risks.
A Phase 1 clinical trial of Qnovia's RespiRx handheld inhalable nicotine replacement therapy (NRT) revealed cigarette-comparable nicotine delivery with favorable safety profile.